{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-24-000182","form_type":"8-K","ticker":"PDEX","cik":"0000788920","company_name":"PRO DEX INC","filed_at":"2024-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.924659+00:00","generated_at":"2026-06-06T06:05:59.026519+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pro-Dex Q2 sales up 12% to $12.6M but net income falls to $500K on investment losses; new buyback launched","bullets":["Net sales increased 12% to $12.6M vs $11.3M a year ago; repair revenue from orthopedic surgical handpiece drove growth.","Operating income decreased 32% to $777K from $1.1M, as operating expenses rose 36% to $2.0M.","Net income was $500K ($0.14 diluted EPS) vs $2.8M ($0.75) a year ago, reflecting $40K unrealized investment loss vs $2.7M gain.","For the six-month period, net loss was $115K ($0.03 loss) vs net income of $4.0M ($1.08) a year ago, impacted by $2.6M unrealized investment loss.","Company announced a new stock buy-back program and is reducing inventory levels."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-24-000182","json":"https://secwatch.observer/filing/0001079973-24-000182.json","markdown":"https://secwatch.observer/filing/0001079973-24-000182.md","text":"https://secwatch.observer/filing/0001079973-24-000182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/788920/000107997324000182/0001079973-24-000182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/788920/000107997324000182/pdex_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T06:05:59.026519+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"833245848dcd6618f37c1afc2f09871731f22e35","claim":"PRO DEX INC reported six months ended December 31, 2023 results: revenue $24.5 million, net income Net loss for the six months ended December 31, 2023, was $115,000, EPS $0.03 per diluted share.","evidence_excerpt":"fair value, and the valuation can be highly volatile. Six Months Ended December 31, 2023 Net sales for the six months ended December 31, 2023, increased $2.2 million, or 10%, to $24.5 million from $22.4 million for the six mo nths ended December 31, 2022, due primarily to increased repair revenue from the orthopedic surgical handpiece that we sell to our","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/788920/000107997324000182/0001079973-24-000182-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"six months ended December 31, 2023"},{"label":"Revenue","value":"$24.5 million"},{"label":"Net income","value":"Net loss for the six months ended December 31, 2023, was $115,000"},{"label":"EPS","value":"$0.03 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"dd8fe73e88ccdcdc0fb9c0a128485d3a92a28fcc","claim":"PRO DEX INC reported fiscal 2024 second quarter ended December 31, 2023 results: revenue $12.6 million, net income $500,000, EPS $0.14 per diluted share.","evidence_excerpt":"Net sales for the three months ended December 31, 2023, increased $1.3 million, or 12%, to $12.6 million from $11.3 million for the three months ended December 31, 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/788920/000107997324000182/0001079973-24-000182-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal 2024 second quarter ended December 31, 2023"},{"label":"Revenue","value":"$12.6 million"},{"label":"Net income","value":"$500,000"},{"label":"EPS","value":"$0.14 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}